Galera Therapeutics, Inc. GRTX
17.15 USD 0.00 (+0.00%)
Aug 3, 2026, 2:11 PM EDT
16.00 Day range 17.15
0.01 52-week range 16.70
- YTD
- +77,854.55%
- 1 year
- +59,037.93%
News
businesswire.com Obsidian Therapeutics Completes Closing of Transaction with Galera Therapeutics and Previously Announced Private Placement of $350 Million CAMBRIDGE, Mass.--(BUSINESS WIRE)--Obsidian Therapeutics, Inc. (“Obsidian”) (Nasdaq: OBX), a clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop…
defenseworld.net Galera Therapeutics (NASDAQ:GRTX) vs. Eagle Pharmaceuticals (NASDAQ:EGRX) Head to Head Review Profitability This table compares Galera Therapeutics and Eagle Pharmaceuticals' net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets Galera Therapeutics…
businesswire.com GRTX Stock Alert: Halper Sadeh LLC is Investigating Whether Galera Therapeutics, Inc. is Obtaining a Fair Price for its Shareholders NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the merger of Galera Therapeutics, Inc. (OTC: GRTX) and Obsidian Therapeutics, Inc. Upon closing of the…
globenewswire.com Galera Therapeutics and Obsidian Therapeutics Announce Merger Agreement and $350 Million Concurrent Private Placement CAMBRIDGE, Mass. and MALVERN, Pa., April 14, 2026 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (“Galera”) (OTC: GRTX), a clinical-stage biopharmaceutical company focused on advancing a pan-NOS…
globenewswire.com $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Galera Therapeutics, Inc. (OTCMKTS: GRTX) NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders…
businesswire.com Obsidian Therapeutics and Galera Therapeutics Announce Merger Agreement and $350 Million Concurrent Private Placement CAMBRIDGE, Mass. & MALVERN, Pa.--(BUSINESS WIRE)--Galera Therapeutics, Inc. (“Galera”) (OTC: GRTX), a clinical-stage biopharmaceutical company focused on advancing a pan-NOS inhibitor through…
defenseworld.net Athersys (NASDAQ:ATHX) and Galera Therapeutics (NASDAQ:GRTX) Critical Review Risk and Volatility Galera Therapeutics has a beta of 1.96, indicating that its share price is 96% more volatile than the S&P 500. Comparatively, Athersys has a beta of -0.9, indicating that its…
defenseworld.net Critical Review: Galera Therapeutics (NASDAQ:GRTX) versus China Pharma (NYSE:CPHI) Earnings and Valuation This table compares China Pharma and Galera Therapeutics"s top-line revenue, earnings per share and valuation. Gross Revenue Price/Sales Ratio Net Income Earnings Per Share…
globenewswire.com Galera Therapeutics Announces Acquisition of Dismutase Mimetics Portfolio by Toronto-based Biossil for up to $105 Million Galera has entered into an Asset Purchase Agreement with Toronto-based Biossil for Galera's dismutase mimetics portfolio, including all avasopasem and rucosopasem formulations and indications. The…
globenewswire.com Galera Therapeutics completes acquisition of Nova Pharmaceuticals Galera's development strategy shifts from toxicity reduction to anti-cancer therapeutics, with three trials in patients with highly resistant subsets of advanced breast cancer.
globenewswire.com Galera Announces Board Approval of Complete Liquidation and Dissolution MALVERN, Pa., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company historically focused on developing a pipeline of novel,…
benzinga.com Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session 
globenewswire.com Galera Reports First Quarter 2024 Financial Results and Recent Corporate Updates MALVERN, Pa., May 13, 2024 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing a pipeline of novel, proprietary therapeutics…
globenewswire.com Galera Adopts Limited Duration Stockholder Rights Agreement MALVERN, Pa., May 03, 2024 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a biopharmaceutical company focused on developing a pipeline of novel, proprietary therapeutics that have the…
benzinga.com Why Doma Holdings Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarket Shares of Doma Holdings Inc. (NYSE: DOMA) rose sharply in today’s pre-market trading after the company entered a merger transaction with TRG to go private at $6.29 per share in cash. Doma Holdings…
benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session 
globenewswire.com Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Updates Company continues to evaluate strategic options to maximize shareholder value Company continues to evaluate strategic options to maximize shareholder value
benzinga.com Galera Therapeutics And 2 Other Stocks Under $3 Insiders Are Buying The Dow Jones index closed lower by over 50 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders…- benzinga.com Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session Shares of WD-40 Company (NASDAQ: WDFC) rose sharply during Wednesday’s session after the company reported better-than-expected first-quarter results.
benzinga.com Why JetBlue Airways Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session Shares of JetBlue Airways Corporation (NASDAQ: JBLU) fell sharply during Tuesday’s session.- benzinga.com Earnings Scheduled For November 14, 2023 Companies Reporting Before The Bell • CureVac (NASDAQ:CVAC) is likely to report quarterly loss at $0.24 per share on revenue of $18.00 million.
globenewswire.com Galera Reports Third Quarter 2023 Financial Results and Recent Corporate Updates FDA confirms need for new trial for avasopasem; GRECO trials with rucosopasem to be discontinued Company evaluating potential strategic options to optimize shareholder value MALVERN, Pa., Nov. 14,…- benzinga.com Why JetBlue Airways Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 80% to $6.14 after the company announced it received notice of acceptance from the Australian patent office for its patent application for…
globenewswire.com Galera Announces Receipt of Type A Meeting Minutes and Strategic Update FDA confirms need for new trial for avasopasem for severe oral mucositis (SOM) GRECO-2 trial did not pass futility analysis; Company will discontinue both GRECO trials Company reviewing potential…
benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session - benzinga.com Stocks That Hit 52-Week Lows On Tuesday Tuesday saw 132 companies set new 52-week lows.
globenewswire.com Galera Schedules Type A Meeting with FDA to Discuss Next Steps for Avasopasem MALVERN, Pa., Sept. 18, 2023 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel,…
benzinga.com Stocks That Hit 52-Week Lows On Friday Friday's session saw 225 companies set new 52-week lows.
benzinga.com Top 5 Health Care Stocks That May Explode In Q3 - BioVie (NASDAQ:BIVI), Galera Therapeutics (NASDAQ:GRTX) The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
zacks.com All You Need to Know About Galera Therapeutics, Inc. (GRTX) Rating Upgrade to Buy Galera Therapeutics, Inc. (GRTX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For August 16, 2023
- benzinga.com Stocks That Hit 52-Week Lows On Monday During Monday's session, 201 stocks hit new 52-week lows.
zacks.com 3 Biotech Stocks Poised to Beat Q2 Earnings Estimates We look at a few biotech companies, LEGN, KOD, GRTX, which are poised to beat second-quarter earnings estimates.
benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 128 companies set new 52-week lows.
benzinga.com Why Krispy Kreme Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session Gainers Edible Garden AG Incorporated (NASDAQ: EDBL) shares jumped 58% to $1.88 after the company reported better-than-expected second-quarter financial results.- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For August 10, 2023
benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session - benzinga.com Why Hims & Hers Health Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket Gainers Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) shares surged 83.5% to $0.1648 in pre-market trading after falling over 25% on Monday. The company recently announced its plans to reduce the…
- benzinga.com Pancreatic Cancer Action Network Urges Advocates From All 50 States To Call On Congress To Increase Federal Funding For Pancreatic Cancer Research Federal Funding Increases Fuel Research Progress and Help Improve Patient OutcomesLOS ANGELES, June 14, 2023 /PRNewswire/ -- The Pancreatic Cancer Action Network (PanCAN), a leading pancreatic cancer…
- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For February 21, 2023
- benzinga.com Why Golden Ocean Group Is Trading Higher By 7%; Here Are 28 Stocks Moving Premarket Gainers
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 120 companies achieved new lows for the year.
- benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday, 137 stocks made new 52-week lows.
- benzinga.com This Healthcare Stock Surges Around 115%, Here's 74 Biggest Movers From Yesterday Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) shares surged 114.3% to close at $0.2550 on Wednesday after the company announced it has terminated its previously announced at-the-market offering.
- benzinga.com 110 Biggest Movers From Friday Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 154.9% to close at $0.51. ShiftPixy reported board approval special dividend to shareholders in form of common shares of Industrial Human Capital.
- benzinga.com 65 Biggest Movers From Yesterday Gainers Brickell Biotech, Inc. (NASDAQ: BBI) shares jumped 58.6% to settle at $0.33 on Tuesday after HC Wainwright & Co initiated coverage on the stock with a Buy rating and $2 price target.
- benzinga.com 46 Biggest Movers From Yesterday Gainers Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) gained 34.1% to settle at $12.58 on Wednesday.
- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2021
- benzinga.com Stocks That Hit 52-Week Lows On Monday Monday morning saw 78 companies set new 52-week lows.
- benzinga.com 64 Biggest Movers From Friday Gainers Hertz Global Holdings (NYSE: HTZ) stock climbed 142.7% to close at $2.50 on Friday following news the company secured $1.65 billion in debtor-in-possession financing commitments.